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Abstract 
The main objective of this presentation is to review the RBE simulation models considered for application in 
hadrontherapy planning treatment. We focus on the two most advanced models for clinical application which are 
the Microdosimetric Kinetic Model and the Local effect Model. We present the formalism of the both models 
and a comparison of their basic concepts. Then we apply the MKM using the published data for HSG cell lines 
in order to compare our results with other published MKM results for the same cell line. Finally we apply the 
MKM for head and neck squamous cell carcinomas (SCC61 and SQ20B Cells) exposed to high LET ions. The 
results obtained with the Microdosimetric Kinetic model are analyzed and the model parameters of the SCC61 
and SQ20B cell lines are compared in term of radiosensitivity to high-LET ions. We have seen that the 
parameters obtained in this study for both cell lines reflect the difference in their radiosensitivity. All these 
results are discussed in terms of parameter analysis and comparison between cell lines, benefits and limits of the 
MK model and leads to some prospects.  
Introduction 
Cell survival to ionizing radiations is a relevant biological endpoint to plan radiotherapy and hadrontherapy 
treatments since it can be linked to the probability of tumor control. Generally, cell survival is estimated by in-
vitro measurements of cell-survival curves. To be integrated into a treatment planning system, experimental data 
have to be accurately reproduced by a model, which can predict survival values at any dose. In the field of 
radiotherapy with light ions (hadrontherapy), cell survival depends not only on dose, but also on ion species and 
ion energy. Consequently, a complex model is needed in order to take into account for the biological dependence 
of the radiation. Then, several models have been proposed to describe the biological efficiency of radiation on 
cells. The assumptions and formalisms of these models evolve with the development of knowledge in 
radiobiology. However the complexity of the radiochemical and radiobiological mechanisms involved in the 
formation of biological damages complicates the elaboration of such models. Consequently, some models, based 
on assumptions and approximations extrapolated from experimental results allow useful predictions. Most of the 
recent models are based on micrometric and nanometric scale calculation. Among others, two models have been 
the subject of study and development in the context of applications to hadrontherapy treatment planning. These 
models are the Local Effect Model (LEM) [1][2] and the Microdosimetric Kinetic Model (MKM) [3][4]. The 
LEM is already used in clinical routine in Germany [5] and the MKM is seriously considered by NIRS group, 
which has published several studies testing this model in order to adapt it to their treatment planning system 
[6][7]. Therefore, we focus in this paper on both these models and applied the MKM model to three cell lines.  
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Material and method 
1. The LEM formalism  
To predict cell survival, the Local Effect Model (LEM), considers that cell killing arises from the induction of 
lethal events by the ionizing radiation. Assuming that the distribution of lethal events obeys a Poisson 
distribution, the probability for the cell to survive reads:                    
                                                                       
lethalN (D)S(D) e−=                                                             (1) 
Where lethalN (D)  is the mean number of lethal events induced in the cell after a dose D. The first key 
assumption of the LEM is to consider lethal events as point-like events generated by the local dose deposited by 
the radiation. Thus, the number of lethal events in the cell is the summation of the local lethal events over the 
cell sensitive volume: 
                                                      lethal lethal
Sensitive Volume
N (D) ( )dρ= ∫∫∫ r r                                            (2) 
Where the local density of lethal events is assumed to be a simple function of the local dose d(r): 
                                                       lethal lethal( ) (d( ))ρ ρ=r r                                                    (3) 
In the LEM, the local dose is calculated by cumulative effects, superimposing the local dose deposited by each 
ion, which is represented by the radial dose Rd : 
                                                     R i
i
d( ) d (r )=∑r                                     (4) 
Where ir  is the radial distance of the point r  to the trajectory of the ith ion in the transversal plane to the beam 
axis.  
The second key assumption of the LEM consists in extracting the relation between the density of lethal events 
and the local dose from survival measurements performed with X-ray radiation. Indeed, the local dose deposited 
by X-ray radiation is considered as uniform within the cell. Neglecting stochastic effects, it is therefore equal to 
the macroscopic dose D , which is delivered to the sample by the X-ray source: 
                                                      d( ) D=r                                      (5) 
Therefore for X-ray irradiation, Eq. (2) becomes simply: 
                                         lethal lethal sensitiveN (D) (D).Vρ≈                               (6) 
According to equation (2), Nlethal(D), and therefore lethal (D)ρ can be deduced from the measurement of cell 
survival to X-ray irradiation (described by the α and β parameters) and from an estimation of the cell sensitive 
volume Vsensitive. This latter is assumed to be uniformly distributed over the cell nucleus. The diameter of the 
sensitive volume depends on the cell and ranges from 5-20 µm. An explicit expression for the average number of 
lethal events can thus be obtained as: 
                                      
X
lethal
sensitiveSensitive  Volume
lnS (d(r))N d
V
−
= ∫∫∫ r                                (7) 
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The photon dose-effect relation is parameterized using an additional parameter, the threshold dose      ,  allowing 
extrapolating the radiation effect to very high dose. This special parameterization is presented in equation (8) :  
2
X X
2
X X seuil X seuil
D(r)+ D (r)             si    D(r)
ln ( ( ))
( +2 D )D (r)- D    si    D (r)>
seuil
seuil
D
S D r
D
α β
α β β
 ≤
− = 

         (8) 
Practically, the threshold dose cannot be measures and is fitted using experimental data measured for high-LET 
ions [8]. 
The LEM authors have changed their model by incorporating the effect of ionization clusters [9] and by 
modifying the parameterization of the radial dose in integrating an expression of the minimum radial distance 
rmin dependent on ion energy. However, the basic formalism of the LEM is still the same. The basic concepts of 
this model was extensively analyzed by Beuve et al [10][11]. 
2. The MKM formalism  
The MK model is based on the statistical theory and the microdosimetric formalisms and quantities. In the MK 
model, the lesions are produced in sub-volumes of the cell nucleus called ”domains”. The dose deposited in these 
domains is quantified by the so-called “specific energy” stochastic variable z . The lesions are classified into two 
different types [12], Type I are lethal and non-repairable, type II are initially not lethal but may become lethal if 
they undergo some specific transformations. The probability of forming a type I lesion in a domain is 
proportional to the dose absorbed by the domain z . The non-lethal type II lesions may be repaired or 
transformed to lethal lesions. The processes that the type II lesions may undergo are 1°) a monomolecular-like 
process with first-order rate constant a. 2°) a pairwise combination with another type II lesion located in the 
same domain to form a lethal unrepairable lesion with second-order rate constant b. 3°) a repair process by a 
monomolecular-like process with first-order rate constant c.4°) a persistence for a period of time tr, after which it 
becomes lethal and not repairable. These possibilities are resumed in figure 1. 
 
Figure 1: Schematic representation of the MKM formalism 
For a short time irradiation and assuming a Poisson distribution of lethal lesions, the mean number of lesions in 
nucleus  is expressed by: 
2( ) pD D Dε α β= +             (9) 
Where the index p indicates the Poisson distribution; 10( )Dp zα α β
−
= +  and 0α  and β  are cell-
dependent but LET independent parameters; 1Dz
−
 is the single event dose mean specific energy in the domain. 
Therefore the expression of 
1P
RBE in the limit of the zero dose is given by:  
1
0
1 Dp
R R
R B E z
α β
α α
−
= +                  (10) 
tD
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Replacing 
1Dz
−
 by its expression versus the mean dose lineal energy 
D
y
−
assuming spherical domain, equation 
(10) reads:  
0
1
0.2
²
Dp
R R
RBE y
d
α β
α α
−
= +
            (11) 
This expression allows deducing the two parameters 0α  and the domain diameter d by fitting experimental data 
for LET below the saturation effect. The value of β  is deduced from the X rays radiation and assumed to be 
unchanged with changing LET or particle type.   
However, for the very high-LET ions, the distribution of lethal lesions in the nucleus cannot be described by a 
Poisson distribution and the RBE value decreases with increasing LET. Then, Equation (10) requires a correction 
in order to take into account for this saturation effect in RBE. This correction was proposed by R.B Hawkins 
[12]:  
1
1
1 1
(1-exp( ))
Dn
Dn
p
P
R p
z
RBE RBE
z
αα
α α
−
−
−
= =
           (12) 
Where 1Dnz
−
is the dose mean specific energy in the nucleus. It is expressed as a function of Dy
−
 by:  
1 0 . 1 6 DD n
y
z
σ
−
−
=    Gy                 (13) 
Where σ  is the cross sectional area of the sensitive nuclear volume expressed in µm²  
If one replaces 1Dnz
−
, pα and 1PRBE given respectively by equations (13), (9) and (11), in the equation (12), 
one can express the corrected linear coefficient of dose by equation (13).  
0
*
0.2
0.16( )
²1- exp
0.16
D D
D
y y
d
y
α β
σ
α σ
− −
−
   − +                 
=                   (14) 
Finally the equation (14) is fitted with experimental data for large LET range in order to deduce the value ofσ . 
3. The LEM vs MKM comparison  
An interesting conceptual comparison was published by Y. Kase et al 2008 [13]. In their work, Kase et al have 
adapted the MKM to amorphous track calculation in order to compare it to the LEM.  We present here some 
conclusions of this comparison.  
In the LEM, the biological effect is related to an energy deposition in infinitesimal small nuclear sub-volume 
assimilated to point-like target (Scholz et al 1996 [1]).  Regarding the MKM, the biological effect is related to an 
energy deposition in nuclear sub-volumes with micrometric dimensions named “Domains”. The domain is a 
small homogeneous reaction vessel with boundary that is impermeable to lesions. (Hawkins 2003 [12]).  Both 
models need the photon dose-effect relation as an input parameter. In addition, the LEM needs the radial dose 
distribution of the incident ions. The LEM parameterization of this dose effect relation is presented in the 
equation (8). In the case of LEM the        parameter is considered as dependent of the LET and the particle type. 
For the MKM the photon dose-effect relation  is parameterized by the linear quadratic model whatever the dose 
range and the       parameter is considered independent of the particle LET and type. In the case of the MKM the 
β
β
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additional input parameters are the lineal energy distribution in the domain and the experimental RBE-LET 
relation for at least two different LET values. 
In the LEM the critical parameter is the threshold dose       , used in the parameterization of the experimental 
photon dose-effect relation for high dose. It is practically difficult to precisely determine the photon dose effect 
at very high dose. Then,        is kept as an adjustable parameter in  order to allow the best representation of the 
experimental data [8]. In the case of the MKM, Kase et al [13] have reported that the model predictions are 
sensitive to relative variations of the domain size. Finally, both models provide a good description for different 
sets of experimental data. However, for some LET–energy combinations, the agreement with the experimental 
results is better with the MKM. Finally, Kase et al reported in their paper that there is a tendency for 
overestimation of RBE by the LEM model for high energetic ions at comparably low LET (Kase et al  [13]) .  
Results 
Application of the MKM with experimental data of Furusawa et al[14] 
The user needs to establish two experimental relations to calculate the necessary parameters of the MK model. 
These parameters are used later to characterize the cell radiosenstivity and predict the response of this cell to ion 
irradiation. These two experimental relations are 1°) the photon dose-effect relation of the cell. This relation is 
used to extract the domain diameter d. 2°) The RBE-LET relation which allow to calculate 0α   and σ . Then, 
we followed these steps to apply the MKM on experimental data published by Furusawa et al [14] for HSG cell 
line irradiated with carbon ion in aerobic conditions. The fitting of the photon dose-effect relation by the linear 
quadratic model resulted in the determination of the parameters: 
X
α =0,313Gy-1 and β =0,062 Gy-2. The index x 
indicates that the alpha parameter is calculated for the X rays irradiation.  
The second step of the MKM-parameter calculation is the determination of the domain diameter     and the 
effective area of the sensitive volumeσ . These two parameters are extracted from the RBE-LET or RBE-lineal 
energy relation.  Then we determine the domain diameter according to the equation (11) and the effective area of 
the HSG cells according to the equation (14). The result of these adjustments are shown in figure 2 .  
 
Figure 2: results of our MKM parameter calculation for HSG cell line irradiated with carbon ions of different 
energies. The experimental data are extracted from Furusawa et al. [14].  
Therefore, the domain radius of the HSG cells is 0,45
d
r µm=  and their effective nucleus area 
is 275µmσ = .  If we assume that the nucleus sensitive volume has a cylindrical shape with radius 
n
R  and 
tD
tD
d
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area σ . Thereforeσ , can be expressed by: 2
n
Rσ π= . By replacing σ  and π   we obtain 4,88
n
R µm=  
for HSG cell line. 
The MKM was also applied for HSG cell by  Kase et al (2006) [15]. In their work Kase et al. have used the 
dose-effect of 200 KV X rays and of 290 MeV/n carbon ions to extract the domain diameter and 
0
α  parameter. 
However, they used another formula to correct the saturation effect and extract the nucleus effective area using 
the lineal energy saturation (details are presented in reference [15]).  The table 1 resumes the MKM parameters 
obtained by our application of the original MKM and those obtained by Kase et al [15].  
Table 1.  Comparison of our application of the MKM with those of Kase et al[15] on the HSG cell line 
MKM Parameters for 
HSG cell line  
Our application of the 
MKM 
Y.  Kase et al results 
β (Gy-2) 0,0615 0,05 
0α (Gy-1) 0,11 ± 0,02 0,13 ± 0,03 
d
r
 (µm) 
0,45 ± 0.05 0,42 ± 0,04 
n
R
 (µm) 
4,88 ± 0,4 4,1 
 
The modified formulation used by Kase and al [15] can explain the difference between our calculation of 
n
R  
and that of Kase et al .  Concerning  
d
r  and 
0
α , these  parameters are extracted using  the original formulation 
of the MKM in both cases. We note that Kase et al [15] used as input, the dose-effect relation based on two 
experimental relations determined by an irradiation with 200 kV photons and with 290 MeV /n carbon ions, in 
order to fit the linear equation expressed in equation (10). Instead we used a larger set of experimental data. 
Despite this, the differences between the both calculation results are acceptable taking into account the 
uncertainties associated to each calculation.  
Application of the MKM to characterize two cell lines with different radio-sensitivities 
The MK model is applied here to reproduce the experimental data of the irradiation of two cell lines. The cell 
lines used in this study are extracted from the same histological type of head and neck carcinoma. The first one is 
the radiosensitive SCC61 cells, extracted from a pharynx carcinoma. The second line is the radioresistant SQ20B 
cells, extracted from a neck carcinoma. These cells are prepared and cultured as described in reference [16]. The 
irradiation procedures and the results of theses irradiations was reported by Beuve et al (2008) [8]. The cells 
were irradiated with carbon ions of 72 MeV/n and with 85 MeV/n argon ions at GANIL facility in France. The 
energies mentioned above are the ion energies at the entrance of the cells. X-ray irradiations of both cell lines 
were performed using the same experimental protocols as used for ion irradiations. This is very important in 
order to compare the high-LET radiation results with the X rays ones. The approach used previously to calculate 
the MKM parameters for the HSG cell line is followed here in order to calculate the MKM parameters for 
SQ20B and SSC61 cell lines. The figure 3 below presents the data adjustment of the alpha parameter versus the 
dose mean lineal energy in the domain according to the equation (14).  The calculated parameters, with this fit, 
are summarized in the Table 2.  We note that in this case, we do an MKM application similar to that made by Y 
Kase et al [15]. This application is based on the use of two experimental dose-response relations obtained with 
photon irradiation and with low LET ion (72 MeV/n carbon ions), in order to estimate the domain size. However, 
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for the estimation of the effective nucleus area, we used the original formulation of the MKM with an additional 
experimental relation obtained using a very high LET (85 MeV/n argon ions).  
                                                                                 Table 2 : MKM parameters calculated for                                
SCC61 and SQ20B cell lines 
                                                                                                           
 
 
 
 
 
Figure 3: Results of MKM parameter calculation for SQ20B and SCC61 cell lines irradiated with carbon ions of 
72 MeV/n and argon ions of 85MeV/n. The experimental data are extracted from Beuve et al. [8]. 
Discussion 
The radiobiological significance of the MK model parameters allows an analysis of the biological response of 
the cells and comparison between different cell lines. In the case of SCC61 and SQ20B cell lines, the parameters 
obtained in this study reflect the difference in their radiosensitivity. The first difference consists in α0. A 
mathematical description of this parameter is given by Hawkins [12]. It depend on the formation rate of non-
reparable type I lesions, the formation rate of the lethal lesions by the monomolecular transformation of type II 
lesions and the transformation of the type II lesions to lethal lesion after a period 
r
t  (see section 2 in method and 
result). Therefore, the cell lines which have low or zero value of 
0
α
 
are dominated by
 
the formation of type I 
lesions or the monomolecular transformation of the type II lesions. In our case, the 
0
α
 
value
 
for SCC61 cells is 
higher than for SQ20B. This implies that the lethal lesions produced in SCC61 cells are the result of the type I 
lesions or the monomolecular transformation of the type II lesions.  The β  parameter of the SQ20B cells is 
higher than those of SCC61, this means that the transformation rate of the type II lesions into lethal lesion by the 
bimolecular processes (interaction of two sublesions) is higher in the SQ20B cells. However, the MK model 
assumes that the production rate of type II lesions is constant regardless of the LET. While, the author of the 
MKM relay the type II lesions to the DSB lesions [12], consequently any change in the LET may affect the 
production rate of type II lesions and probably the β . Concerning the parameter σ, which reflects the nuclear 
sensitive volume, is more important in the SCC61 than in SQ20B cell.  
Finally, this behavior of the MKM parameters can be exploited clinically to adapt the radiation depending on the 
degree of radiosensitivity tumor cells based on the model parameters. In this optic, it will be interesting to 
determine a common experimental protocol in order to calculate the MKM parameters and construct a parameter 
tables for each cell line considered in hadrontherapy treatement. 
Conclusion 
We have seen that the application of the MKM in its original version gives comparable results with the MKM 
version used by Kase et al [15] except for the determination of the effective nucleus area where Kase et al [15]   
included a new formula to correct the saturation effect using the lineal energy saturation.  We have also seen that 
the MKM parameters allow characterizing the response mechanisms and the radiosensitivity of a cell lines. The 
MKM parameters calculated for the SCC61 and SQ20B cell lines reflect well their different radiosensitivity. 
MK parameters SCC61 cells SQ20B cells 
β (Gy-2) 0.02 0.0615 
α0 (Gy) 0.57 0.02 
d (µm) 0.88 0.67 
σ (µm²) 55 35 
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Then, this characteristic of the MKM parameters can be beneficial in clinical application of the MKM in order to 
improve treatments by adapting the radiation depending on radiosensitivity of tumor cells. The MK model still 
has some weaknesses especially regarding the change of beta parameter with LET since the MKM assumes that 
the β  is independent of particle type and energy used. The α and β  parameters are expressed in the MKM as a 
function of several other parameters related to production rates of type II and type I lesions and to their kinetic 
evolution in the cell. It assumes also that the production rate of type II lesions is constant regardless of the LET 
and is equal to 30 lesions / Gy. However, the MKM relay the type II lesions to the DSB lesions [12], 
consequently any change in the LET may affect the production rate of type II lesions and probably the β .  
For the prospects of RBE modeling for hadrontherapy treatments, we adopted two approaches. The first 
approach is to continue the investigations of MKM in order to better understand the behavior of its parameters in 
different biological conditions. We are working on changing the expression given the production rate of type II 
lesions in order to include the influence of the LET.  For this, we rely on the experimental data we are producing 
by irradiation with x-rays and carbon ions (at GANIL) of several types of cell lines following a well-defined 
protocol.  
The second approach is to develop a new model, which in particular will include concept or element inspired 
from the models presently available in the literature and we considered as key points. 
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I. Introduction
•Radiobiological models are necessary to predict the biological effect of 
radiation in order to perform a rigorous  treatment planning in hadrontherapy.    
• There are several models, based on assumptions and approximations 
extrapolated from experimental results. 
3
•There is two most advanced models for clinical application which are :
- The Microdosimetric Kinetic Model (MKM)  Hawkins 1994 and 1996.  
- The Local effect Model (LEM) Scholz et al 1996
Basic formulation of MKM and LEM
4
The total effect is obtained by
summation of al local effects
through total sensitive volume : 
ln( ( ( ))
( ) X
S Dr
N D dr
−
=∫∫∫
Mathematical formulation: 
1. LEM Scholz et al 1996
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Poisson distribution of lethal
lesions  : 
létal
V
V
( )( ) letalN DionS D e
−=
Energy depositiond
λ dK
dz
Domain diameter d
Hawkins et al 1996
Production constant rate of 
type I lesions :  
Production constant rate of 
type II lesions. 
2. MK Model
6
Type II lesion
Not lethal
Type II lesion
Not lethal
type I Lesion 
Lethal Lethal lesion repaired
cba rt
Complex Damages
Pairwise combination 
of type II lesions
Second order rate 
constant
Reparation 
rate 
constant.
Persistence 
time:
monomolecular 
transformation of 
the type I lesion
First order rate 
constant of : 
Conceptual comparison of the MKM with LEM
7
(Y. Kase et al 2008)
1. Radiosensitive sites
• Both models suppose that the radiosensitive structures are contained in the 
nucleus. These structures considered as  the sub-volumes of the nucleus. 
LEM MKM
The biological effect is related to 
an energy deposition  in infinitesimal small
nuclear sub-volume
The biological effect is related to 
an energy deposition  in nuclear 
sub-volume with micrometric dimension
8
Assimilated to point-like target
(Scholz et al 1996)
Domain
Small homogeneous reaction vessel with 
boundary that is impermeable to lesions.
(Hawkins 2003)
Local effect
2. Photon dose-effect relation
• Both models use the photon dose-effect relation in the determination of the ion 
effect. 
LEM MKM
: Threshold dose, obtained by 
adjusting the experimental data of 
The photon dose-effect relation. 
tD The linear quadratic function of the dose is
used for any value of dose.
9
is not dependent in LET and particle 
type
βchanges with changing LET and 
particle type.
β
3. The energy deposition
• Both models need physical input parameter to calculate the cell response.
LEM MKM
The radial distribution of the dose:
Distribution of the dose at distance r 
from the ion trajectory (In the LEM I).
Microdosimetric spectra :
Distribution of energy deposition in the 
domain                 calculation of        or  
dy
−
dz
−
10
2
min min
min max
min
( / )   si    
( ) ( / ²)    si    
0           si    
r
k LET r r r
D r k LET r r r r
r r
 <

= < <
 >
LEM MKM
4. Critical parameters
• Both models use parameters that could not be directly measured : 
Threshold dose : The domain size :
It is practically difficult to precisely 
determine the photon dose at very high 
dose.   
tD
Domain can not be identified with any 
known structure in the cell. 
d
11
tD is kept as an adjustable parameter in  
order to allow the best representation of
the experimental data.
Obtained by fitting the RBE1-LET
relation at low LET range.   
Linear approximation of the RBE1-LET 
relation in this range of LET
It’s value depends on the LEM version 
considered. 
LEM MKM
In the LEM, the biological response of 
the cell is taken into account by using 
the photon dose-effect relation.  
In the MKM, several parameters are 
used to describe the cell response
and the kinetic evolution of the initial 
5. Cell response
12
There are no parameters describing 
the formation and the kinetic evolution 
of lesions.
lesions.
, al of these 
parameters are considered as 
independent from LET.
d σ 0α β
6. Application of models in treatment planning
• Both models provide a good description for different sets of experimental data.
• However, For some LET–energy combinations, the agreement with the experimental
results is better with the MKM. 
Solid lines :  MKM calculations
dotted lines : initial version LEM 
calculations.
13• There is a tendency for overestimation of RBE by the LEM model for high energetic 
ions.
dashed lines: Modified LEM 
calculations.
Y. Kase et al 2008
Application of the MKM to experimental data
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• In the low LET range : 
Then the relation       vs      is linear
0
0.2
²
dp y
d
α α β
−
= +
pα dy
−
1. Calculation of the biological parameters for HSG cell line :
• experimental data extracted from Furusawa et al  2000, for HSG cell line irradiated 
with carbon ions in aerobic conditions
15
To deduce : 
: initial slop of the survival  curve.                 
:  domain’s diameter.
0α
d
To deduce the effective 
area of the nuclear 
sensitive volume: σ
( / )dy KeV µm
0
0.2
0.16( )
²1- exp
0.16
D D
D
y y
d
y
α β
σ
α σ
− −
−
   − +                 
=
• In the high LET range :
• Calculation of the MKM parameters for HSG cell line by Kase et al  (2006) using as 
input data de dose-effect relations obtained with:
• X rays of 200 KV and carbon ions of 290 MeV/n
2. Comparison of the parameters obtained by Kase et al for HSG cells:
The correction of the saturation 
effect is done using the lineal 
energy saturation in Kase et al  
2006, calculation.
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• The differences between the both calculation results are acceptable taking into account 
the uncertainties associated to each calculation.
• Except for         , where the difference can be explained by the modified formulation of 
the saturation effect used in Kase et al calculation. 
n
R
2,5
3. Calculation of the biological parameters for SCC61 and SQ20B cell 
lines :
 Cell lines : 
• The radiosensitive cell line: SCC61,established from squamous cell carcinomas of 
the pharynx.
• The radioresistant cell line: SQ20B,established from squamous cell carcinomas 
of the neck. 
 We used as input parameters : 
 The experimental dose effect relation obtained with 250 KV X rays.
 Experimental data obtained at GANIL with 72 MeV/n carbon ions and 85 MeV/n
argon ions
Beuve et al  2008
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y = 0,0236x - 0,0227
y = 0,015x + 0,575
0
0,5
1
1,5
2
0 200 400 600 800
SCC61
SQ20B
SCC61_Exp
SQ20B_Exp
( / )dy KeV µm
Domain’s diameter         :
0αd σ
4. Discussion of the MKM parameters for SCC61 et SQ20B cells
Cell line
(µm) (Gy-1) (µm²)
SCC61 0.88 0.57 55
SQ20B 0.67 0.02 35
d
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•Domain = distance a  type II lesion can travel through the nucleus before it is 
removed by repair.
•The low difference of the domain size between the two cell lines can not 
explain the difference in radiosensitivity of the two cell lines.
parameter (depends in K and λ parameters) :
0αd σ
0α
aK
Cell lines
(µm) (Gy-1) (µm²)
SCC61 0.88 0.57 55
SQ20B 0.67 0.02 35
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• The low value of         indicates that the contribution of the monomolecular 
transformation of the type II lesions is weak                 SQ20B
•The high value of           indicates that the most lethal lesions are produced by 
the monomolecular transformation of the type II lesions SCC61
( )
0
( )
ra c tKe
a c
α λ − += + +
+
0α
0α
σ  parameter :
0αd σCell lines
(µm) (G-1) (µm²)
SCC61 0.88 0.57 55
SQ20B 0.67 0.02 35
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The difference in σ value of  both cell lines reflect probably
Difference in the distribution of the nuclear sensitive structures between the two 
cell lines. 
• A strength of both models is that due to the simplicity and the computational 
speed of the calculations, they are both applicable for treatment planning.
• the MKM and the LEM rely on the same three basic constituents of target
geometry, photon survival curve and track structure.
Conclusions  and prospects:
21
however, their implementation of these constituents is significantly different.
• In both models, the photon dose-effect relation is not sufficient to calculate the 
ion response. 
Additional information about the biological response to ion irradiation is 
necessary to determine the domain size in MKM or the threshold dose in 
LEM.
Conclusions and prospects :
• The MKM parameters calculated reflect the difference in cell radiosensitivity.
this characteristic can be beneficial in clinical application of the MKM in order 
to improve treatments.
• The MK model still has some weaknesses especially regarding the change of beta 
parameter with LET. 
22
• We are working on changing the expression given the 
production rate of type II lesions in order to include the 
influence of the LET on the      parameter.
• To use Geant4 DNA to apply MKM in microdosimetrical 
context .
• Develop a new model, which in particular will include concept or element 
inspired from the models presently available in the literature and we 
considered as key points.
β
